Cell and circuit complexity of the external globus pallidus

CD Courtney, A Pamukcu, CS Chan - Nature neuroscience, 2023 - nature.com
The external globus pallidus (GPe) of the basal ganglia has been underappreciated owing
to poor understanding of its cells and circuits. It was assumed that the GPe consisted of a …

Molecular pathophysiological mechanisms in Huntington's disease

A Jurcau - Biomedicines, 2022 - mdpi.com
Huntington's disease is an inherited neurodegenerative disease described 150 years ago
by George Huntington. The genetic defect was identified in 1993 to be an expanded CAG …

Disrupted striatal neuron inputs and outputs in Huntington's disease

A Reiner, YP Deng - CNS neuroscience & therapeutics, 2018 - Wiley Online Library
Huntington's disease (HD) is a hereditary progressive neurodegenerative disorder caused
by a CAG repeat expansion in the gene coding for the protein huntingtin, resulting in a …

Synaptic dysfunction in Huntington's disease: lessons from genetic animal models

C Cepeda, MS Levine - The Neuroscientist, 2022 - journals.sagepub.com
The understanding of the functional and structural changes occurring in the cerebral cortex
and basal ganglia in Huntington's disease (HD) has benefited considerably from the …

SREBP2 gene therapy targeting striatal astrocytes ameliorates Huntington's disease phenotypes

G Birolini, G Verlengia, F Talpo, C Maniezzi, L Zentilin… - Brain, 2021 - academic.oup.com
Brain cholesterol is produced mainly by astrocytes and is important for neuronal function. Its
biosynthesis is severely reduced in mouse models of Huntington's disease. One possible …

Ginsenoside Rg1 exerts neuroprotective effects in 3-nitropronpionic acid-induced mouse model of Huntington's disease via suppressing MAPKs and NF-κB pathways …

X Yang, S Chu, Z Wang, F Li, Y Yuan… - Acta Pharmacologica …, 2021 - nature.com
Huntington's disease (HD) is one of main neurodegenerative diseases, characterized by
striatal atrophy, involuntary movements, and motor incoordination. Ginsenoside Rg1 (Rg1) …

Progression of basal ganglia pathology in heterozygous Q175 knock‐in Huntington's disease mice

Y Deng, H Wang, M Joni, R Sekhri… - Journal of Comparative …, 2021 - Wiley Online Library
We used behavioral testing and morphological methods to detail the progression of basal
ganglia neuron type‐specific pathology and the deficits stemming from them in male …

Differential changes to D1 and D2 medium spiny neurons in the 12-month-old Q175+/- mouse model of Huntington's Disease

JW Goodliffe, H Song, A Rubakovic, W Chang… - PloS one, 2018 - journals.plos.org
Huntington's Disease (HD) is an autosomal dominant, progressive neurodegenerative
disorder caused by deleterious expansion of CAG repeats in the Huntingtin gene and …

Dysregulation of the basal ganglia indirect pathway in early symptomatic Q175 Huntington's Disease Mice

JW Callahan, DL Wokosin, MD Bevan - Journal of Neuroscience, 2022 - Soc Neuroscience
The debilitating psychomotor symptoms of Huntington9s disease (HD) are linked partly to
degeneration of the basal ganglia indirect pathway. At early symptomatic stages, before …

Striatonigral neurons divide into two distinct morphological-physiological phenotypes after chronic L-DOPA treatment in parkinsonian rats

T Fieblinger, L Zanetti, I Sebastianutto, LS Breger… - Scientific reports, 2018 - nature.com
Dendritic regression of striatal spiny projection neurons (SPNs) is a pathological hallmark of
Parkinson's disease (PD). Here we investigate how chronic dopamine denervation and …